PureTech Health (PRTC) Shares Outstanding (Weighted Average) (2019 - 2025)
PureTech Health (PRTC) reported Shares Outstanding (Weighted Average) of $4.9 million for Q4 2025, down 98.09% year-over-year from $254.5 million in Q4 2024, and little changed quarter-over-quarter from $4.9 million in Q2 2025.
PureTech Health (PRTC) Shares Outstanding (Weighted Average) (2019 - 2025) Analysis & Trends
PureTech Health (PRTC) has 7 years of Shares Outstanding (Weighted Average) data on file, last reported at $4.9 million in Q4 2025.
- Shares Outstanding (Weighted Average) for Q4 2025 came in at $4.9 million, down 98.09% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.9 million (down 98.09% YoY), and the FY2025 annual result was $4.9 million, down 98.09% from the prior year.
- Shares Outstanding (Weighted Average) steadied at $4.9 million in Q4 2025 per PRTC's latest filing, from $4.9 million in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $287.8 million in Q4 2021 and troughed at $150.0 in Q2 2024.
- A 5-year average of $157.5 million and a median of $254.5 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
- On a YoY basis, Shares Outstanding (Weighted Average) climbed as much as 3239900.0% in 2025 and fell as far as 98.09% in 2025.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $287.8 million in 2021, then dropped by 3.21% to $278.6 million in 2022, then slipped by 2.41% to $271.9 million in 2023, then declined by 6.4% to $254.5 million in 2024, then plunged by 98.09% to $4.9 million in 2025.
- Business Quant data shows PRTC's Shares Outstanding (Weighted Average) at $4.9 million in Q4 2025, $4.9 million in Q2 2025, and $254.5 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 185,491.37 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 400.00 Bn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4,489.46 Bn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 100.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 417.01 Bn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 118.76 Bn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 68.88 Bn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 254.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 928.40 Mn |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | 4.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.86 Mn |
| Jun 30, 2025 | 4.86 Mn |
| Dec 31, 2024 | 254.46 Mn |
| Jun 30, 2024 | 150.00 |
| Dec 31, 2023 | 271.85 Mn |
| Dec 31, 2022 | 278.57 Mn |
| Dec 31, 2021 | 287.80 Mn |
| Dec 31, 2020 | 285.89 Mn |
| Dec 31, 2019 | 285.37 Mn |